$1.320
+0.031 (+2.33%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SNOA por análisis de gráficos similares
Alphio's SNOA stock price prediction model matches the current Sonoma Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.33 (+0.44%). The 1-week path is $1.32 (+0.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Sonoma Pharmaceuticals Inc?
Sonoma Pharmaceuticals Inc (SNOA) is currently trading at $1.31 with a forward P/E ratio of 46.08, indicating high future earnings expectations despite recent losses. The stock has a current RSI of 43.68, suggesting it is nearing oversold territory, but the year-to-date change of -64.01% raises concerns about its long-term viability. The recent FDA clearance for its Microdacyn product could drive future growth, but the significant net losses, including a net loss of $581,000 in Q4 2026, present a risk that investors should consider before buying.
SNOA cerró en $1.32 el Thursday, tras subir +2.33%
Sonoma Pharmaceuticals Inc (SNOA) last closed at $1.32, gaining +2.33%. These facts feed the 1-day and 1-week SNOA price prediction above.
Consenso de analistas
Sonoma Pharmaceuticals Inc (SNOA): 2 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Sonoma Pharmaceuticals Inc (SNOA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SNOA, ordenadas por similitud.
Análisis de estacionalidad de SNOA
Historically the probability of a positive September return for SNOA is 56.82%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SNOA
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $3.03 | $3.34 | $3.67 | +152.89% |
| Oct 2026 | $3.71 | $4.46 | $5.24 | +238.16% |
| Nov 2026 | $3.30 | $3.86 | $4.03 | +192.80% |
| Dec 2026 | $3.78 | $4.08 | $4.90 | +209.29% |
En 2026, se proyecta que Sonoma Pharmaceuticals Inc (SNOA) oscile entre $3.03 y $5.24.
Previsión mensual de Sonoma Pharmaceuticals Inc para 2026
En Sep de 2026, se proyecta que Sonoma Pharmaceuticals Inc promedie $3.34, con un mínimo de $3.03 y un máximo de $3.67.
En Oct de 2026, se proyecta que Sonoma Pharmaceuticals Inc promedie $4.46, con un mínimo de $3.71 y un máximo de $5.24.
En Nov de 2026, se proyecta que Sonoma Pharmaceuticals Inc promedie $3.86, con un mínimo de $3.30 y un máximo de $4.03.
En Dec de 2026, se proyecta que Sonoma Pharmaceuticals Inc promedie $4.08, con un mínimo de $3.78 y un máximo de $4.90.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.